Nemaura Medical Inc.
Company Snapshot: Nemaura Medical Inc.
NMRD | ||||
Last | Change | Volume | High | Low |
Company Overview

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes specialty medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. The company was founded in 2009 and is headquartered in Loughborough, the United Kingdom.
Client News
- Aug 15 2022 Nemaura Medical Reports Fiscal First Quarter 2023 Results and Provides Business Update
- Jul 21 2022 Nemaura Medical Granted UK Trademark “Meta Score,” a Digital Biomarker Term for its Metabolic Health Program
- Jun 30 2022 Nemaura Medical Reports Financial Results and Provides Business Update for the Fiscal Year Ended March 31, 2022
- May 23 2022 Nemaura Medical Strengthens Balance Sheet with Further Non-Dilutive Funding